Literature DB >> 23306667

Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient management.

Hanna Eriksson1, Margareta Frohm-Nilsson, Mari-Anne Hedblad, Henrik Hellborg, Lena Kanter-Lewensohn, Kamilla Krawiec, Barbro Lundh Rozell, Eva Månsson-Brahme, Johan Hansson.   

Abstract

Clinical management of primary cutaneous melanomas is based on histopathological staging of the tumour. The aim of this study was to investigate, in a non-selected population in clinical practice, the agreement rate between general pathologists and pathologists experienced in melanoma in terms of the evaluation of histopathological prognostic parameters in cutaneous malignant melanomas, and to what extent the putative variability affected clinical management. A total of 234 cases of invasive cutaneous malignant melanoma were included in the study from the Stockholm-Gotland Healthcare Region in Sweden. Overall interobserver variability between a general pathologist and an expert review was 68.8-84.8%. Approximately 15.5% of melanomas ≤1 mm were re-classified either as melanoma in situ or melanomas >1 mm after review. In conclusion, review by a pathologist experienced in melanoma resulted in a change in recommendations about surgical excision margins and/or sentinel node biopsy in subgroups of T1 melanomas.

Entities:  

Mesh:

Year:  2013        PMID: 23306667     DOI: 10.2340/00015555-1517

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  7 in total

1.  Routine screening pelvic examinations have a negative effect on patients.

Authors:  Robert W Shepherd
Journal:  Can Fam Physician       Date:  2016-08       Impact factor: 3.275

Review 2.  Investigation of cAMP microdomains as a path to novel cancer diagnostics.

Authors:  Garrett Desman; Caren Waintraub; Jonathan H Zippin
Journal:  Biochim Biophys Acta       Date:  2014-09-07

3.  Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?

Authors:  Laura A Taylor; Megan M Eguchi; Lisa M Reisch; Andrea C Radick; Hannah Shucard; Kathleen F Kerr; Michael W Piepkorn; Stevan R Knezevich; David E Elder; Raymond L Barnhill; Joann G Elmore
Journal:  Cancer       Date:  2021-05-04       Impact factor: 6.860

4.  Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization.

Authors:  Jonhan Ho; Stefan M Ahlers; Curtis Stratman; Orly Aridor; Liron Pantanowitz; Jeffrey L Fine; John A Kuzmishin; Michael C Montalto; Anil V Parwani
Journal:  J Pathol Inform       Date:  2014-08-28

5.  Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Authors:  Joann G Elmore; Raymond L Barnhill; David E Elder; Gary M Longton; Margaret S Pepe; Lisa M Reisch; Patricia A Carney; Linda J Titus; Heidi D Nelson; Tracy Onega; Anna N A Tosteson; Martin A Weinstock; Stevan R Knezevich; Michael W Piepkorn
Journal:  BMJ       Date:  2017-06-28

6.  Concordance and Reproducibility of Melanoma Staging According to the 7th vs 8th Edition of the AJCC Cancer Staging Manual.

Authors:  Joann G Elmore; David E Elder; Raymond L Barnhill; Stevan R Knezevich; Gary M Longton; Linda J Titus; Martin A Weinstock; Margaret S Pepe; Heidi D Nelson; Lisa M Reisch; Andrea C Radick; Michael W Piepkorn
Journal:  JAMA Netw Open       Date:  2018-05

7.  Artificial neural network in the discrimination of lung cancer based on infrared spectroscopy.

Authors:  Eiron John Lugtu; Denise Bernadette Ramos; Alliah Jen Agpalza; Erika Antoinette Cabral; Rian Paolo Carandang; Jennica Elia Dee; Angelica Martinez; Julius Eleazar Jose; Abegail Santillan; Ruth Bangaoil; Pia Marie Albano; Rock Christian Tomas
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.